Compare Hubbell (HUBB) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hubbell vs Immunovant Inc. Common Stock — how do they compare? Hubbell trades at $474.9 (market cap $25.12B), while Immunovant Inc. Common Stock trades at $30.48 (market cap $6.25B). The key difference: Hubbell is far larger — about 4× Immunovant Inc. Common Stock's market cap, and Hubbell pays a 1.19% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hubbell for 4 Days and Immunovant Inc. Common Stock for 1 Days on average.
| HUBB | IMVT | |
|---|---|---|
Market Cap | $25.12B | $6.25B |
Volume | 784,557 | 1,755,411 |
Sector | Industrials | Health |
52-Week High | $557.85 | $44.96 |
52-Week Low | $407.36 | $17.03 |
Typical Hold Time | 4 Days | 1 Days |
Enterprise Value | $30.28B | $5.35B |
Dividend Yield | 1.19% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Hubbell
Hubbell manufactures electrical and utility products used in transmission, distribution, and electrical infrastructure. Its portfolio includes components and systems for utilities, data centers, industrial facilities, and buildings.
Read more on HUBB →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
